{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:26:03Z","timestamp":1790479563175,"version":"4.1.0"},"reference-count":290,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T00:00:00Z","timestamp":1633824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology","doi-asserted-by":"publisher","award":["DBT-843-BIO"],"award-info":[{"award-number":["DBT-843-BIO"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SER-1058-BIO"],"award-info":[{"award-number":["SER-1058-BIO"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Systemic candidiasis is an invasive fungal infection caused by members of the genus Candida. The recent emergence of antifungal drug resistance and increased incidences of infections caused by non-albicans Candida species merit the need for developing immune therapies against Candida infections. Although the role of cellular immune responses in anti-Candida immunity is well established, less is known about the role of humoral immunity against systemic candidiasis. This review summarizes currently available information on humoral immune responses induced by several promising Candida vaccine candidates, which have been identified in the past few decades. The protective antibody and B-cell responses generated by polysaccharide antigens such as mannan, \u03b2-glucan, and laminarin, as well as protein antigens like agglutinin-like sequence gene (Als3), secreted aspartyl proteinase (Sap2), heat shock protein (Hsp90), hyphally-regulated protein (Hyr1), hyphal wall protein (Hwp1), enolase (Eno), phospholipase (PLB), pyruvate kinase (Pk), fructose bisphosphate aldolase (Fba1), superoxide dismutase gene (Sod5) and malate dehydrogenase (Mdh1), are outlined. As per studies reviewed, antibodies induced in response to leading Candida vaccine candidates contribute to protection against systemic candidiasis by utilizing a variety of mechanisms such as opsonization, complement fixation, neutralization, biofilm inhibition, direct candidacidal activity, etc. The contributions of B-cells in controlling fungal infections are also discussed. Promising results using anti-Candida monoclonal antibodies for passive antibody therapy reinforces the need for developing antibody-based therapeutics including anti-idiotypic antibodies, single-chain variable fragments, peptide mimotopes, and antibody-derived peptides. Future research involving combinatorial immunotherapies using humanized monoclonal antibodies along with antifungal drugs\/cytokines may prove beneficial for treating invasive fungal infections.<\/jats:p>","DOI":"10.3390\/vaccines9101159","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T01:59:47Z","timestamp":1633917587000},"page":"1159","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["The Role of B-Cells and Antibodies against Candida Vaccine Antigens in Invasive Candidiasis"],"prefix":"10.3390","volume":"9","author":[{"given":"Manisha","family":"Shukla","sequence":"first","affiliation":[{"name":"Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, UTT, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7034-7614","authenticated-orcid":false,"given":"Pankaj","family":"Chandley","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, UTT, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0953-3132","authenticated-orcid":false,"given":"Soma","family":"Rohatgi","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, UTT, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4161\/viru.22913","article-title":"Candida albicans pathogenicity mechanisms","volume":"4","author":"Duncan","year":"2013","journal-title":"Virulence"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3314\/jjmm.48.1","article-title":"Trends in the epidemiology of invasive fungal infections","volume":"48","author":"Warnock","year":"2007","journal-title":"Jpn. J. Med. Mycol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Calandra, T., Roberts, J.A., Antonelli, M., Bassetti, M., and Vincent, J.L. (2016). Diagnosis and management of invasive candidiasis in the ICU: An updated approach to an old enemy. Crit. Care, 20.","DOI":"10.1186\/s13054-016-1313-6"},{"key":"ref_4","first-page":"1","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive Candidiasis","volume":"373","author":"Kullberg","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Ahmad, S., and Alfouzan, W. (2021). Candida auris: Epidemiology, diagnosis, pathogenesis, antifungal susceptibility, and infection control measures to combat the spread of infections in healthcare facilities. Microorganisms, 9.","DOI":"10.3390\/microorganisms9040807"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Gintjee, T.J., Donnelley, M.A., and Thompson, G.R. (2020). Aspiring Antifungals: Review of Current Antifungal Pipeline Developments. J. Fungi, 6.","DOI":"10.3390\/jof6010028"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Bhattacharya, S., Sae-Tia, S., and Fries, B.C. (2020). Candidiasis and mechanisms of antifungal resistance. Antibiotics, 9.","DOI":"10.3390\/antibiotics9060312"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Papon, N., Courdavault, V., Clastre, M., Bennett, R.J., and Nac, N.-C. (2013). Emerging and Emerged Pathogenic Candida Species: Beyond the Candida albicans Paradigm. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003550"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cyto.2015.07.025","article-title":"Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species","volume":"76","author":"Whibley","year":"2015","journal-title":"Cytokine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.biopha.2018.12.009","article-title":"Current antifungal drugs and immunotherapeutic approaches as promising strategies to treatment of fungal diseases","volume":"110","author":"Nami","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/mmy\/myu029","article-title":"New insights into innate immune control of systemic candidiasis","volume":"52","author":"Lionakis","year":"2014","journal-title":"Med. Mycol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1590\/0074-02760150335","article-title":"Del New insights on the development of fungal vaccines: From immunity to recent challenges","volume":"110","author":"Medici","year":"2015","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1517\/14712598.6.9.891","article-title":"Host defence against disseminated Candida albicans infection and implications for antifungal immunotherapy","volume":"6","author":"Vonk","year":"2006","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.01471","article-title":"Candida and Complement: New Aspects in an Old Battle","volume":"11","author":"Harpf","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1128\/IAI.00233-09","article-title":"Complement C3 plays an essential role in the control of opportunistic fungal infections","volume":"77","author":"Tsoni","year":"2009","journal-title":"Infect. Immun."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Brown, G.D., Denning, D.W., Gow, N.A.R., Levitz, S.M., Netea, M.G., and White, T.C. (2012). Hidden killers: Human fungal infections. Sci. Transl. Med., 4.","DOI":"10.1126\/scitranslmed.3004404"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.4049\/jimmunol.158.9.4328","article-title":"B cell-independent selection of memory T cells after mucosal immunization with Candida albicans","volume":"158","author":"Balish","year":"1997","journal-title":"J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.4049\/jimmunol.152.10.5000","article-title":"Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis","volume":"152","author":"Qian","year":"1994","journal-title":"J. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.micinf.2004.05.013","article-title":"Human dendritic cells are less potent at killing Candida albicans than both monocytes and macrophages","volume":"6","author":"Netea","year":"2004","journal-title":"Microbes Infect."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/infdis\/jit413","article-title":"Inflammatory monocytes mediate early and organ-specific innate defense during systemic candidiasis","volume":"209","author":"Ngo","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.4049\/jimmunol.163.3.1498","article-title":"Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans","volume":"163","author":"Netea","year":"1999","journal-title":"J Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nri3897","article-title":"Immune defence against Candida fungal infections","volume":"15","author":"Netea","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.1128\/IAI.69.11.6813-6822.2001","article-title":"Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells","volume":"69","author":"Newman","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1189\/jlb.0503226","article-title":"The interaction of human dendritic cells with yeast and germ-tube forms of","volume":"75","author":"Romagnoli","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Lionakis, M.S., and Netea, M.G. (2013). Candida and Host Determinants of Susceptibility to Invasive Candidiasis. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003079"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1188\/07.CJON.29-32","article-title":"Diagnosing fungal infections in neutropenic patients","volume":"11","author":"Gardner","year":"2007","journal-title":"Clin. J. Oncol. Nurs."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Uppuluri, P., Singh, S., Alqarihi, A., Schmidt, C.S., Hennessey, J.P., Yeaman, M.R., Filler, S.G., Edwards, J.E., and Ibrahim, A.S. (2018). Human Anti-Als3p antibodies are surrogate markers of NDV-3A vaccine efficacy against recurrent vulvovaginal candidiasis. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01349"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e00312","DOI":"10.1128\/IAI.00312-20","article-title":"Vaccination with secreted aspartyl proteinase 2 protein from candida parapsilosis can enhance survival of mice during c. tropicalis-mediated systemic candidiasis","volume":"88","author":"Shukla","year":"2020","journal-title":"Infect. Immun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/eji.201343828","article-title":"Differential role of NK cells against Candida albicans infection in immunocompetent or immunocompromised mice","volume":"44","author":"Quintin","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/eji.201747450","article-title":"Proteome analysis of human CD56 neg NK cells reveals a homogeneous phenotype surprisingly similar to CD56 dim NK cells","volume":"48","author":"Voigt","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1128\/CVI.00606-12","article-title":"Natural killer cells and antifungal host response","volume":"20","author":"Schmidt","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.micinf.2010.03.013","article-title":"Host responses to Candida albicans: Th17 cells and mucosal candidiasis","volume":"12","author":"Conti","year":"2010","journal-title":"Microbes Infect."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12281-010-0034-6","article-title":"T-cell subsets and antifungal host defenses","volume":"4","author":"Netea","year":"2010","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/21505594.2015.1004977","article-title":"Adaptive immune responses to Candida albicans infection","volume":"6","author":"Richardson","year":"2015","journal-title":"Virulence"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.chom.2012.04.008","article-title":"Th17 cells in immunity to Candida albicans","volume":"11","author":"Gaffen","year":"2012","journal-title":"Cell Host Microbe"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00281-014-0464-2","article-title":"The cross-talk between opportunistic fungi and the mammalian host via microbiota\u2019s metabolism","volume":"37","author":"Romani","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1086\/422329","article-title":"Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice","volume":"190","author":"Huang","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/SHK.0b013e3181d67041","article-title":"Differential effects of IL-17 pathway in disseminated candidiasis and zymosan-induced multiple organ failure","volume":"34","author":"Kullberg","year":"2010","journal-title":"Shock"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Lin, L., Ibrahim, A.S., Xu, X., Farber, J.M., Avanesian, V., Baquir, B., French, S.W., Edwards, J.E., and Spellberg, B. (2009). Th1-Th17 Cells Mediate Protective Adaptive Immunity against Staphylococcus aureus and Candida albicans Infection in Mice. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000703"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/IAI.74.5.3039-3041.2006","article-title":"The anti-candida vaccine based on the recombinant N-terminal domain of Als1p is broadly active against disseminated candidiasis","volume":"74","author":"Ibrahim","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jlb.51.3.305","article-title":"Differential effects of CD4+ and CD8+ cells in acute, systemic murine candidosis","volume":"51","author":"Coker","year":"1992","journal-title":"J. Leukoc. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1099\/13500872-145-7-1631","article-title":"Both CD4+ and CD8+ lymphocytes reduce the severity of tissue lesions in murine systemic candidiasis, and CD4+ cells also demonstrate strain-specific immunopathological effects","volume":"145","author":"Ashman","year":"1999","journal-title":"Microbiology"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Mody, C.H., and Oykhman, P. (2010). Direct microbicidal activity of cytotoxic T-lymphocytes. J. Biomed. Biotechnol., 2010.","DOI":"10.1155\/2010\/249482"},{"key":"ref_45","first-page":"1970","article-title":"IFN-g in Candida albicans infections","volume":"14","year":"2009","journal-title":"Front. Biosci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1439-0507.2011.02078.x","article-title":"Innate and adaptive antifungal immune responses: Partners on an equal footing","volume":"55","author":"Hamad","year":"2012","journal-title":"Mycoses"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.coi.2012.04.007","article-title":"Immunity to fungi","volume":"24","author":"Hohl","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2141.2005.05498.x","article-title":"Cytokines and fungal infections","volume":"129","author":"Antachopoulos","year":"2005","journal-title":"Br. J. Haematol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1469-0691.2011.03676.x","article-title":"Adjunctive immunotherapy with recombinant cytokines for the treatment of disseminated candidiasis","volume":"18","author":"Kullberg","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Pathakumari, B., Liang, G., and Liu, W. (2020). Immune defence to invasive fungal infections: A comprehensive review. Biomed. Pharmacother., 130.","DOI":"10.1016\/j.biopha.2020.110550"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/515645","article-title":"Candidiasis in interferon-gamma knockout (IFN-gamma-\/-) mice","volume":"178","author":"Balish","year":"1998","journal-title":"J. Infect. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/jlb.57.4.651","article-title":"Effects of granulocyte colony-stimulating factor and interferon-\u03b3 on antifungal activity of human polymorphonuclear neutrophils against pseudohyphae of different medically important Candida species","volume":"57","author":"Roilides","year":"1995","journal-title":"J. Leukoc. Biol."},{"key":"ref_53","first-page":"117","article-title":"Characterisation of Candida albicans infections of haematogenous and mucosal origin in mice lacking the interferon \u03b3 receptor protein","volume":"27","author":"Londono","year":"2000","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1128\/iai.60.11.4950-4952.1992","article-title":"Gamma interferon modifies CD4+ subset expression in murine candidiasis","volume":"60","author":"Romani","year":"1992","journal-title":"Infect. Immun."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-14-166","article-title":"Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: A case series","volume":"14","author":"Delsing","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1002\/eji.200323737","article-title":"Differential role of IL-18 and IL-12 in the host defense against disseminated Candida albicans infection","volume":"33","author":"Netea","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1874-5172(99)80018-2","article-title":"Cellular mechanisms of phagocytosis of Candida by murine macrophages","volume":"6","author":"Gordon","year":"1999","journal-title":"Adv. Cell. Mol. Biol. Membr. Organelles"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2174\/1389201003378924","article-title":"Cytokines in candidiasis and aspergillosis","volume":"1","author":"Mencacci","year":"2000","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.4049\/jimmunol.1500870","article-title":"Delinking CARD9 and IL-17: CARD9 Protects against Candida tropicalis Infection through a TNF-\u03b1\u2013Dependent, IL-17\u2013Independent Mechanism","volume":"195","author":"Whibley","year":"2015","journal-title":"J. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1086\/503363","article-title":"Endogenous Interleukin (IL)\u20131 a and IL-1 b Are Crucial for Host Defense against Disseminated Candidiasis","volume":"193","author":"Vonk","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3892\/br.2014.365","article-title":"Early expression of local cytokines during systemic Candida albicans infection in a murine intravenous challenge model","volume":"2","author":"Chin","year":"2014","journal-title":"Biomed. Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.4049\/jimmunol.154.10.5273","article-title":"Growth inhibition of Candida albicans hyphae by CD8+ lymphocytes","volume":"154","author":"Beno","year":"1995","journal-title":"J. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1369-5274(99)80064-2","article-title":"Immunity to Candida albicans: Th1, Th2 cells and beyond","volume":"2","author":"Romani","year":"1999","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-280X.1999.00247.x","article-title":"Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice","volume":"37","author":"Netea","year":"1999","journal-title":"Med. Mycol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/infdis\/jis383","article-title":"Interleukin-7 Ameliorates Immune Dysfunction and Improves Survival in a 2-Hit Model of Fungal Sepsis","volume":"206","author":"Unsinger","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_66","first-page":"1","article-title":"Immunity to fungi","volume":"24","author":"Romani","year":"2007","journal-title":"New Insights Med. Mycol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/eji.1830240419","article-title":"Interleukin-12 but not interferon-gamma production correlates with induction of T helper type-1 phenotype in murine candidiasis","volume":"24","author":"Romani","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/IAI.70.6.3284-3286.2002","article-title":"Role of Interleukin-18 in Host Defense against Disseminated Candida albicans Infection","volume":"70","author":"Stuyt","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Whitney, P.G., B\u00e4r, E., Osorio, F., Rogers, N.C., Schraml, B.U., Deddouche, S., LeibundGut-Landmann, S., and Reis e Sousa, C. (2014). Syk Signaling in Dendritic Cells Orchestrates Innate Resistance to Systemic Fungal Infection. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004276"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Nur, S., Sparber, F., Lemberg, C., Guiducci, E., Schweizer, T.A., Zwicky, P., Becher, B., and LeibundGut-Landmann, S. (2019). IL-23 supports host defense against systemic Candida albicans infection by ensuring myeloid cell survival. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1008115"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-02977-5","article-title":"Microbiota-driven interleukin-17 production provides immune protection against invasive candidiasis","volume":"24","author":"Li","year":"2020","journal-title":"Crit. Care"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Huppler, A.R., Bishu, S., and Gaffen, S.L. (2012). Mucocutaneous candidiasis: The IL-17 pathway and implications for targeted immunotherapy. Arthritis Res. Ther., 14.","DOI":"10.1186\/ar3893"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"780","DOI":"10.4049\/jimmunol.1500909","article-title":"IL-17\u2013Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans","volume":"195","author":"Conti","year":"2015","journal-title":"J. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1128\/IAI.01398-09","article-title":"Impairment of host defense against disseminated candidiasis in mice overexpressing GATA-3","volume":"78","author":"Haraguchi","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1084\/jem.187.3.307","article-title":"Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans","volume":"187","author":"Mencacci","year":"1998","journal-title":"J. Exp. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.4049\/jimmunol.155.3.1349","article-title":"TGF-beta is important in determining the in vivo patterns of susceptibility or resistance in mice infected with Candida albicans","volume":"155","author":"Spaccapelo","year":"1995","journal-title":"J. Immunol."},{"key":"ref_77","first-page":"316","article-title":"Studies of the role of B-cells in the resistance of mice to experimental candidiasis","volume":"266","author":"Sinha","year":"1987","journal-title":"Zentralbl Bakteriol. Mikrobiol. Hyg. A"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0090-1229(84)90308-8","article-title":"Immunodeficient CBA\/N mice respond effectively to Candida albicans","volume":"33","author":"Carrow","year":"1984","journal-title":"Clin. Immunol. Immunopathol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/02681218880000401","article-title":"Immunomodulation by a low-virulence, agerminative variant of candida albicans. Further evidence for macrophage activation as one of the effector mechanisms of nonspecific anti-infectious protection","volume":"26","author":"Bistoni","year":"1988","journal-title":"Med. Mycol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/infdis\/167.4.912","article-title":"Resistance of SCID Mice to Candida albicans Administered Intravenously or Colonizing the Gut: Role of Polymorphonuclear Leukocytes and Macrophages","volume":"167","author":"Balish","year":"1993","journal-title":"J. Infect. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/infdis\/170.4.900","article-title":"The role of phagocytic cells in resistance to disseminated candidiasis in granulocytopenic mice","volume":"170","author":"Jensen","year":"1994","journal-title":"J. Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/infdis\/174.3.589","article-title":"B cell knockout mice are resistant to mucosal and systemic candidiasis of endogenous origin but susceptible to experimental systemic candidiasis","volume":"174","author":"Wagner","year":"1996","journal-title":"J. Infect. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1128\/IAI.70.9.4791-4797.2002","article-title":"Immune cell-mediated protection against vaginal candidiasis: Evidence for a major role of vaginal CD4+ T cells and possible participation of other local lymphocyte effectors","volume":"70","author":"Santoni","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1567-1364.2010.00620.x","article-title":"Protection against rat vaginal candidiasis by adoptive transfer of vaginal B lymphocytes","volume":"10","author":"Santoni","year":"2010","journal-title":"FEMS Yeast Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/art.30314","article-title":"The anti-CD20 antibody rituximab reduces the Th17 cell response","volume":"63","author":"Lauwerys","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.01472-17","article-title":"Immune Protection against Lethal Fungal-Bacterial Intra-Abdominal Infections","volume":"9","author":"Lilly","year":"2018","journal-title":"mBio"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1084\/jem.20100034","article-title":"Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina","volume":"207","author":"Rapaka","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1462-5822.2006.00786.x","article-title":"Host defence against C. albicans infections in IgH transgenic mice with VH derived from a natural anti-keratin antibody","volume":"9","author":"Li","year":"2007","journal-title":"Cell. Microbiol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Tian, R., Fu, M., Zhang, Z., Ren, J., An, J., Liu, Y., and Li, W. (2013). In Situ IgM Production and Clonal Expansion of B-1 Cells in Peritoneal Cavity Promote Elimination of C. albicans Infection in IgH Transgenic Mice with VH Derived from a Natural Antibody. PLoS ONE, 8.","DOI":"10.1371\/annotation\/bedab014-d393-4fad-aa07-0df1efb59038"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Rudkin, F.M., Raziunaite, I., Workman, H., Essono, S., Belmonte, R., MacCallum, D.M., Johnson, E.M., Silva, L.M., Palma, A.S., and Feizi, T. (2018). Single human B cell-derived monoclonal anti-Candida antibodies enhance phagocytosis and protect against disseminated candidiasis. Nat. Commun., 9.","DOI":"10.1038\/s41467-018-07738-1"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.4049\/jimmunol.1601572","article-title":"Antibody-Independent Function of Human B Cells Contributes to Antifungal T Cell Responses","volume":"198","author":"Li","year":"2017","journal-title":"J. Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S1369-5274(02)00337-5","article-title":"Induced humoral immunity and vaccination against major human fungal pathogens","volume":"5","author":"Casadevall","year":"2002","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0003-9969(82)90184-4","article-title":"The effect of secretory immunoglobulin A on the in-vitro adherence of the yeast Candida albicans to human oral epithelial cells","volume":"27","author":"Vudhichamnong","year":"1982","journal-title":"Arch. Oral. Biol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00436540","article-title":"Role of antibodies and effect of BCG vaccination in experimental candidiasis in mice","volume":"91","author":"Maiti","year":"1985","journal-title":"Mycopathologia"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/1566524054022549","article-title":"An Outline of the Role of Anti-Candida Antibodies Within the Context of Passive Immunization and Protection from Candidiasis","volume":"5","author":"Cassone","year":"2005","journal-title":"Curr. Mol. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1128\/IAI.00083-07","article-title":"Anticandidal immunity and vaginitis: Novel opportunities for immune intervention","volume":"75","author":"Cassone","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_97","first-page":"182","article-title":"Immunohistochemical study of in vivo and in vitro IgA coating of candida species in vulvovaginal candidiasis","volume":"70","author":"Bohler","year":"1994","journal-title":"Genitourin. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1590\/S0104-42302003000400037","article-title":"IgA, IgE and IgG subclasses to Candida albicans in serum and vaginal fluid from patients with vulvovaginal candidiasis","volume":"49","author":"Cunha","year":"2003","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1086\/509891","article-title":"Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis","volume":"195","author":"Liu","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1128\/iai.63.7.2714-2719.1995","article-title":"Antibody response that protects against disseminated candidiasis","volume":"63","author":"Han","year":"1995","journal-title":"Infect. Immun."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.femsim.2004.03.012","article-title":"Antibody response to Candida albicans cell wall antigens","volume":"41","author":"Casanova","year":"2004","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.actbio.2016.05.001","article-title":"Protective effect of antigen delivery using monoolein-based liposomes in experimental hematogenously disseminated candidiasis","volume":"39","author":"Carneiro","year":"2016","journal-title":"Acta Biomater."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1128\/CVI.05215-11","article-title":"Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis","volume":"18","author":"Xin","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Wan Tso, G.H., Reales-Calderon, J.A., and Pavelka, N. (2018). The Elusive Anti-Candida Vaccine: Lessons from the past and opportunities for the future. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00897"},{"key":"ref_105","first-page":"309","article-title":"Vaccines in the treatment of invasive candidiasis","volume":"6","author":"Wang","year":"2015","journal-title":"Virulence"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.femsim.2004.12.012","article-title":"Role of anti-beta-glucan antibody in host defense against fungi","volume":"44","author":"Masaharu","year":"2005","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc9365","article-title":"The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: Recommendations from the Third European Conference on Infections in Leukemia","volume":"14","author":"Mikulska","year":"2010","journal-title":"Crit. Care"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1128\/iai.65.10.4100-4107.1997","article-title":"Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies","volume":"65","author":"Han","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1128\/iai.65.12.5354-5357.1997","article-title":"A monoclonal antibody to Candida albicans enhances mouse neutrophil candidacidal activity","volume":"65","author":"Cutler","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1128\/iai.63.7.2619-2624.1995","article-title":"Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection","volume":"63","author":"Cassone","year":"1995","journal-title":"Infect. Immun."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1128\/iai.65.8.3399-3405.1997","article-title":"Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats","volume":"65","author":"Boccanera","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0008-8749(89)90081-6","article-title":"Direct activation of human B lymphocytes by Candida albicans-derived mannan antigen","volume":"122","author":"Mangeney","year":"1989","journal-title":"Cell. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1128\/IAI.66.12.5771-5776.1998","article-title":"A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection","volume":"66","author":"Han","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1128\/iai.65.9.3822-3827.1997","article-title":"Mannan-Specific Immunoglobulin G Antibodies in Normal Human Serum Mediate Classical Pathway Initiation of C3 Binding to Candida albicans","volume":"65","author":"Zhang","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1128\/IAI.66.12.6027-6029.1998","article-title":"Contrasting roles of mannan-specific monoclonal immunoglobulin M antibodies in the activation of classical and alternative pathways by Candida albicans","volume":"66","author":"Zhang","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1128\/cdli.4.3.328-333.1997","article-title":"Differential humoral response against \u03b1- and \u03b2-linked mannose residues associated with tissue invasion by Candida albicans","volume":"4","author":"Jouault","year":"1997","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1086\/314779","article-title":"Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis","volume":"179","author":"Han","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1128\/IAI.68.3.1649-1654.2000","article-title":"Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody","volume":"68","author":"Han","year":"2000","journal-title":"Infect. Immun."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.4049\/jimmunol.167.3.1550","article-title":"Complement Is Essential for Protection by an IgM and an IgG3 Monoclonal Antibody Against Experimental, Hematogenously Disseminated Candidiasis","volume":"167","author":"Han","year":"2001","journal-title":"J. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2174\/1566524054022576","article-title":"Defining Criteria for Anti-Mannan Antibodies to Protect Against Candidiasis","volume":"5","author":"Cutler","year":"2005","journal-title":"Curr. Mol. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1021\/cb300345e","article-title":"Design of a Candida albicans disaccharide conjugate vaccine by reverse engineering a protective monoclonal antibody","volume":"7","author":"Bundle","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1128\/IAI.68.6.3297-3304.2000","article-title":"Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans","volume":"68","author":"Santoni","year":"2000","journal-title":"Infect. Immun."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0165-2478(02)00241-9","article-title":"Candida albicans mannan-protein conjugate as vaccine candidate","volume":"85","year":"2003","journal-title":"Immunol. Lett."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/IAI.72.1.209-218.2004","article-title":"Biological Activities of Naturally Occurring Antibodies Reactive with Candida albicans Mannan","volume":"72","author":"Kozel","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/IAI.74.1.362-369.2006","article-title":"Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice","volume":"74","author":"Zhang","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.molimm.2008.10.008","article-title":"Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans","volume":"46","author":"Boxx","year":"2009","journal-title":"Mol. Immunol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/IAI.00890-15","article-title":"Influence of IgG subclass on human antimannan antibody-mediated resistance to hematogenously disseminated candidiasis in mice","volume":"84","author":"Nishiya","year":"2016","journal-title":"Infect. Immun."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1039\/b709912f","article-title":"Synthesis and immunochemical studies on a Candida albicans cluster glycoconjugate vaccine","volume":"5","author":"Wu","year":"2007","journal-title":"Org. Biomol. Chem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1002\/chem.200800352","article-title":"Synthesis and immunochemical characterization of 5-linked glycoconjugate vaccines against Candida albicans","volume":"14","author":"Wu","year":"2008","journal-title":"Chem. A Eur. J."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.intimp.2007.05.014","article-title":"Cell and antibody mediated immunity induced by vaccination with novel Candida dubliniensis mannan immunogenic conjugate","volume":"7","year":"2007","journal-title":"Int. Immunopharmacol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1515\/znc-2008-11-1222","article-title":"Growth inhibition of Candida albicans in the presence of antiserum elicited in rabbits by mannan-protein conjugate","volume":"63","year":"2008","journal-title":"Z. Naturforsch. C J. Biosci."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"13526","DOI":"10.1073\/pnas.0803195105","article-title":"Synthetic glycopeptide vaccines combining \u03b2-mannan and peptide epitopes induce protection against candidiasis","volume":"105","author":"Xin","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Xin, H., Cartmell, J., Bailey, J.J., Dziadek, S., Bundle, D.R., and Cutler, J.E. (2012). Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0035106"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1574-695X.2009.00642.x","article-title":"Model \u03b1-mannoside conjugates: Immunogenicity and induction of candidacidal activity","volume":"58","author":"Karelin","year":"2010","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1021\/bc100397b","article-title":"Synthesis and immunogenicity of a glycopolymer conjugate","volume":"22","author":"Lipinski","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"6263","DOI":"10.1016\/j.vaccine.2012.08.010","article-title":"A \u03b2-mannan trisaccharide conjugate vaccine aids clearance of Candida albicans in immunocompromised rabbits","volume":"30","author":"Lipinski","year":"2012","journal-title":"Vaccine"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.intimp.2012.07.004","article-title":"Humoral and cell-mediated immunity following vaccination with synthetic Candida cell wall mannan derived heptamannoside-protein conjugate: Immunomodulatory properties of heptamannoside-BSA conjugate","volume":"14","author":"Karelin","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s12272-012-1120-9","article-title":"Comparison of two Candida mannan vaccines: The role of complement in protection against disseminated candidiasis","volume":"35","author":"Han","year":"2012","journal-title":"Arch. Pharm. Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/sji.12044","article-title":"Effect of branched \u03b1-oligomannoside structures on induction of anti-candida humoral immune response","volume":"77","author":"Karelin","year":"2013","journal-title":"Scand. J. Immunol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jmii.2013.08.020","article-title":"Immune cell response to Candida cell wall mannan derived branched \u03b1-oligomannoside conjugates in mice","volume":"48","author":"Karelin","year":"2015","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.4014\/jmb.1410.10050","article-title":"Inhibition of yeast growth by broadly cross-reactive antisera elicited by heterologous mannan-protein conjugate","volume":"25","year":"2015","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejmech.2019.04.001","article-title":"Synthesis and immunological studies of \u03b2-1,2-mannan-peptide conjugates as antifungal vaccines","volume":"173","author":"Liao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Paulovi\u010dov\u00e1, L., Paulovi\u010dov\u00e1, E., Farka\u0161, P., C\u00edzov\u00e1, A., Bystrick\u00fd, P., Jan\u010dinov\u00e1, V., Tur\u00e1nek, J., Pericolini, E., Gabrielli, E., and Vecchiarelli, A. (2019). Bioimmunological activities of Candida glabrata cellular mannan. FEMS Yeast Res., 19.","DOI":"10.1093\/femsyr\/foz009"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-90402-4","article-title":"Dissection of the anti-Candida albicans mannan immune response using synthetic oligomannosides reveals unique properties of \u03b2-1,2 mannotriose protective epitopes","volume":"11","author":"Sendid","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1128\/IAI.70.10.5462-5470.2002","article-title":"Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated candidiasis in recipients of a Candida albicans vaccine","volume":"70","author":"Bromuro","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.20050749","article-title":"A novel glyco-conjugate vaccine against fungal pathogens","volume":"202","author":"Torosantucci","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/IAI.00278-07","article-title":"An anti-\u03b2-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo","volume":"75","author":"Rachini","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Torosantucci, A., Chiani, P., Bromuro, C., De Bernardis, F., Palma, A.S., Liu, Y., Minogna, G., Maras, B., Colone, M., and Stringaro, A. (2009). Protection by anti-\u03b2-glucan antibodies is associated with restricted \u03b2-1,3 glucan binding specificity and inhibition of fungal growth and adherence. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005392"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Cassone, A., Bromuro, C., Chiani, P., and Torosantucci, A. (2010). Hyr1 protein and \u03b2-glucan conjugates as anti-candida vaccines. J. Infect. Dis., 202.","DOI":"10.1086\/657417"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1467-7652.2010.00586.x","article-title":"Plant production of anti-\u03b2-glucan antibodies for immunotherapy of fungal infections in humans","volume":"9","author":"Capodicasa","year":"2011","journal-title":"Plant Biotechnol. J."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.vaccine.2009.12.021","article-title":"A \u03b2-glucan-conjugate vaccine and anti-\u03b2-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique","volume":"28","author":"Pietrella","year":"2010","journal-title":"Vaccine"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1016\/j.vaccine.2010.01.012","article-title":"Beta-glucan-CRM197 conjugates as candidates antifungal vaccines","volume":"28","author":"Bromuro","year":"2010","journal-title":"Vaccine"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.2741\/3199","article-title":"Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies","volume":"13","author":"Magliani","year":"2008","journal-title":"Front. Biosci."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3314\/jjmm.51.99","article-title":"Anti-fungal cell wall \u03b2-glucan antibody in animal sera","volume":"51","author":"Ishibashi","year":"2010","journal-title":"Jpn. J. Med. Mycol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.vaccine.2008.11.030","article-title":"Anti-\u03b2-glucan antibodies in healthy human subjects","volume":"27","author":"Chiani","year":"2009","journal-title":"Vaccine"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-02977-6","article-title":"Antibodies against a \u03b2-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients","volume":"7","author":"Torosantucci","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Zito, A., Bromuro, C., Mandili, G., Chiani, P., Horenstein, A.L., Malavasi, F., Cauda, R., Cassone, A., and Torosantucci, A. (2016). A murine, bispecific monoclonal antibody simultaneously recognizing \u03b2-Glucan and MP65 determinants in Candida species. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0148714"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1128\/IAI.71.11.6205-6212.2003","article-title":"Therapeutic Activity of an Engineered Synthetic Killer Antiidiotypic Antibody Fragment against Experimental Mucosal and Systemic Candidiasis","volume":"71","author":"Polonelli","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Polonelli, L., Beninati, C., Teti, G., Felici, F., Ciociola, T., Giovati, L., Sperind\u00e8, M., Lo Passo, C., Pernice, I., and Domina, M. (2014). Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0105727"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1248\/bpb.29.1848","article-title":"Recombinant single-chain anti-idiotypic antibody: An effective fungal \u03b2-1,3-glucan synthase inhibitor","volume":"29","author":"Selvakumar","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00253-011-3412-2","article-title":"Peptide derived from anti-idiotypic single-chain antibody is a potent antifungal agent compared to its parent fungicide HM-1 killer toxin peptide","volume":"92","author":"Kabir","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Huang, H., Ostroff, G.R., Lee, C.K., Specht, C.A., and Levitz, S.M. (2010). Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded \u03b2-Glucan particles. mBio, 1.","DOI":"10.1128\/mBio.00164-10"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.micinf.2009.11.004","article-title":"Dose-dependent cellular and humoral responses in Galleria mellonella larvae following \u03b2-glucan inoculation","volume":"12","author":"Mowlds","year":"2010","journal-title":"Microbes Infect."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/21505594.2017.1370174","article-title":"Analysis of the early cellular and humoral responses of galleria mellonella larvae to infection by Candida albicans","volume":"9","author":"Sheehan","year":"2018","journal-title":"Virulence"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.4049\/jimmunol.1202937","article-title":"Enhanced Immunogenicity of a Tricomponent Mannan Tetanus Toxoid Conjugate Vaccine Targeted to Dendritic Cells via Dectin-1 by Incorporating \u03b2-Glucan","volume":"190","author":"Lipinski","year":"2013","journal-title":"J. Immunol."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Bundle, D.R., Paszkiewicz, E., Elsaidi, H.R.H., Mandal, S.S., and Sarkar, S. (2018). A three component synthetic vaccine containing a \u03b2-mannan T-cell peptide epitope and a \u03b2-glucan dendritic cell ligand. Molecules, 23.","DOI":"10.3390\/molecules23081961"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1021\/bc500575a","article-title":"Synthesis and Immunological Studies of Linear Oligosaccharides of \u03b2-Glucan As Antigens for Antifungal Vaccine Development","volume":"26","author":"Liao","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1021\/acsinfecdis.5b00104","article-title":"6-O-Branched Oligo-\u03b2-glucan-Based Antifungal Glycoconjugate Vaccines","volume":"2","author":"Liao","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/cmi.12631","article-title":"The evaluation of \u03b2-(1\u21923)-nonaglucoside as an anti-Candida albicans immune response inducer","volume":"18","author":"Yashunsky","year":"2016","journal-title":"Cell. Microbiol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"e0215535","DOI":"10.1371\/journal.pone.0215535","article-title":"Novel mouse monoclonal antibodies specifically recognizing B-(1\u20133)-D-glucan antigen","volume":"14","author":"Matveev","year":"2019","journal-title":"PLoS ONE"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2020.01648","article-title":"Dectin-1 Facilitates IL-18 Production for the Generation of Protective Antibodies Against Candida albicans","volume":"11","author":"Shen","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.4049\/jimmunol.0902477","article-title":"Involvement of the NLRP3 Inflammasome in Innate and Humoral Adaptive Immune Responses to Fungal \u03b2-Glucan","volume":"183","author":"Kumar","year":"2009","journal-title":"J. Immunol."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Seo, B.-S., Lee, S.-H., Lee, J.-E., Yoo, Y.-C., Lee, J., and Park, S.-R. (2013). Dectin-1 Stimulation Selectively Reinforces LPS-driven IgG1 Production by Mouse B Cells. Immune Netw., 13.","DOI":"10.4110\/in.2013.13.5.205"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.20121801","article-title":"A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi","volume":"210","author":"Hoogeboom","year":"2013","journal-title":"J. Exp. Med."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/07328303.2011.604453","article-title":"Synthesis of laminarin fragments and evaluation of a \u03b2-(1,3) glucan hexasaccaride-CRM 197 conjugate as vaccine candidate against Candida albicans","volume":"30","author":"Adamo","year":"2011","journal-title":"J. Carbohydr. Chem."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/CVI.00689-12","article-title":"Adjuvanticity of a recombinant calreticulin fragment in assisting anti-\u03b2-glucan igG responses in T cell-deficient mice","volume":"20","author":"Li","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0167-5699(92)90169-8","article-title":"The role of hsp90 in fungal infection","volume":"13","author":"Matthews","year":"1992","journal-title":"Immunol. Today"},{"key":"ref_178","first-page":"20","article-title":"Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis","volume":"74","author":"Matthews","year":"1991","journal-title":"Immunology"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0022-1759(91)90274-J","article-title":"The application of epitope mapping in the development of a new serological test for systemic candidosis","volume":"143","author":"Matthews","year":"1991","journal-title":"J. Immunol. Methods"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/infdis\/171.6.1668","article-title":"Preliminary Assessment of a Human Recombinant Antibody Fragment to hsp90 in Murine Invasive Candidiasis","volume":"171","author":"Matthews","year":"1995","journal-title":"J. Infect. Dis."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1128\/AAC.47.7.2208-2216.2003","article-title":"Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90","volume":"47","author":"Matthews","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/503428","article-title":"A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis","volume":"42","author":"Pachl","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1345\/aph.1M218","article-title":"Efungumab: A novel agent in the treatment of invasive candidiasis","volume":"43","author":"Karwa","year":"2009","journal-title":"Ann. Pharmacother."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1128\/AAC.01324-10","article-title":"Dose range evaluation of mycograb C28Y variant, a human recombinant antibody fragment to heat shock protein 90, in combination with amphotericin B-desoxycholate for treatment of murine systemic candidiasis","volume":"55","author":"Louie","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1128\/AAC.00435-12","article-title":"Nonspecific effect of mycograb on amphotericin B MIC","volume":"56","author":"Richie","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Bugli, F., Cacaci, M., Martini, C., Torelli, R., Posteraro, B., Sanguinetti, M., and Paroni Sterbini, F. (2013). Human monoclonal antibody-based therapy in the treatment of invasive candidiasis. Clin. Dev. Immunol., 2013.","DOI":"10.1155\/2013\/403121"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02931297","article-title":"Comparison of protective effect of protein and DNA vaccines hsp90 in murine model of systemic candidiasis","volume":"50","author":"Wudattu","year":"2005","journal-title":"Folia Microbiol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1016\/j.vaccine.2004.07.005","article-title":"Prophylactic vaccination with phage-displayed epitope of C. albicans elicits protective immune responses against systemic candidiasis in C57BL\/6 mice","volume":"23","author":"Yang","year":"2005","journal-title":"Vaccine"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1016\/j.vaccine.2006.05.022","article-title":"Protective immune responses against systemic candidiasis mediated by phage-displayed specific epitope of Candida albicans heat shock protein 90 in C57BL\/6J mice","volume":"24","author":"Wang","year":"2006","journal-title":"Vaccine"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/13693780701883508","article-title":"Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis","volume":"46","author":"Raska","year":"2008","journal-title":"Med. Mycol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2011.01.016","article-title":"Metallochelating liposomes with associated lipophilised norAbuMDP as biocompatible platform for construction of vaccines with recombinant His-tagged antigens: Preparation, structural study and immune response towards rHsp90","volume":"151","author":"Koudelka","year":"2011","journal-title":"J. Control. Release"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s11095-014-1516-y","article-title":"Molecular adjuvants based on nonpyrogenic lipophilic derivatives of norAbuMDP\/gmdp formulated in nanoliposomes: Stimulation of innate and adaptive immunity","volume":"32","author":"Zyka","year":"2015","journal-title":"Pharm. Res."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.carbpol.2016.03.024","article-title":"Structural characterization of low molecular weight polysaccharide from Astragalus membranaceus and its immunologic enhancement in recombinant protein vaccine against systemic candidiasis","volume":"145","author":"Yang","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijbiomac.2021.01.105","article-title":"Chitosan hydrogel loaded with recombinant protein containing epitope C from HSP90 of Candida albicans induces protective immune responses against systemic candidiasis","volume":"173","author":"Li","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Hoyer, L.L., and Cota, E. (2016). Candida albicans Agglutinin-Like Sequence (Als) Family Vignettes: A Review of Als Protein Structure and Function. Front Microbiol., 7.","DOI":"10.3389\/fmicb.2016.00280"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"0543","DOI":"10.1371\/journal.pbio.0050064","article-title":"Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells","volume":"5","author":"Phan","year":"2007","journal-title":"PLoS Biol."},{"key":"ref_197","first-page":"71","article-title":"Coleman, a Soon-Hwan Oh, a Xiaomin Zhao, a Hongyuan Zhao, b Jeff, T. Hutchins, b John, H. Vernachio, b Joseph, M. Patti, b and L.L.H. Monoclonal antibodies specific for Candida albicans Als3 that immunolabel fungal cells in vitro and in vivo and block adhesion to host surfaces","volume":"78","author":"David","year":"2009","journal-title":"J. Biotechnol. Methods"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1099\/mic.0.046326-0","article-title":"Candida albicans adhesin Als3p is dispensable for virulence in the mouse model of disseminated candidiasis","volume":"157","author":"Cleary","year":"2011","journal-title":"Microbiology"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0033362","article-title":"Evaluation of the role of Candida albicans agglutinin-like sequence (ALS) proteins in human oral epithelial cell interactions","volume":"7","author":"Murciano","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11046-018-0301-6","article-title":"Different Host Immunological Response to C. albicans by Human Oral and Vaginal Epithelial Cells","volume":"184","author":"Gao","year":"2019","journal-title":"Mycopathologia"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1086\/430952","article-title":"Mice with disseminated candidiasis die of progressive sepsis","volume":"192","author":"Spellberg","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1128\/IAI.73.2.999-1005.2005","article-title":"Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity","volume":"73","author":"Ibrahim","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.1128\/IAI.73.9.6191-6193.2005","article-title":"The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice","volume":"73","author":"Spellberg","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1086\/504691","article-title":"Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis","volume":"194","author":"Spellberg","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/CVI.00427-07","article-title":"Considerable differences in vaccine immunogenicities and efficacies related to the diluent used for aluminum hydroxide adjuvant","volume":"15","author":"Lin","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1128\/IAI.00700-08","article-title":"The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus","volume":"76","author":"Spellberg","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1574-695X.2008.00531.x","article-title":"Immunological surrogate marker of rAls3p-N vaccine-induced protection against Staphylococcus aureus","volume":"55","author":"Lin","year":"2009","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1086\/529204","article-title":"Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity","volume":"197","author":"Spellberg","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/649901","article-title":"Immunological Reactivity of Blood from Healthy Humans to the rAls3p-N Vaccine Protein","volume":"201","author":"Baquir","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1128\/IAI.01840-06","article-title":"Fungicidal monoclonal antibody C7 binds to Candida albicans Als3","volume":"75","author":"Brena","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1574-695X.2008.00502.x","article-title":"Recognition of Candida albicans Als3 by the germ tube-specific monoclonal antibody 3D9.3","volume":"55","author":"Beucher","year":"2009","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1016\/j.vaccine.2012.10.038","article-title":"NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults","volume":"30","author":"Schmidt","year":"2012","journal-title":"Vaccine"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1016\/j.vaccine.2013.09.016","article-title":"NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response","volume":"31","author":"Ibrahim","year":"2013","journal-title":"Vaccine"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"E5555","DOI":"10.1073\/pnas.1415610111","article-title":"Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection","volume":"111","author":"Yeaman","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/cid\/ciy185","article-title":"A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial","volume":"66","author":"Edwards","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-42517-y","article-title":"NDV-3A vaccination prevents C. albicans colonization of jugular vein catheters in mice","volume":"9","author":"Alqarihi","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Singh, S., Uppuluri, P., Alqarihi, A., Elhassan, H., French, S., Lockhart, S.R., Chiller, T., Edwards, J.E., and Ibrahim, A.S. (2019). The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007460"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1128\/MMBR.67.3.400-428.2003","article-title":"Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis","volume":"67","author":"Naglik","year":"2003","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1128\/iai.65.9.3529-3538.1997","article-title":"Disruption of Each of the Secreted Aspartyl Proteinase Genes Attenuates Virulence","volume":"65","author":"Hube","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1128\/iai.65.9.3539-3546.1997","article-title":"A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence","volume":"65","author":"Sanglard","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/314546","article-title":"Evidence that Members of the Secretory Aspartyl Proteinase Gene Family, in Particular SAP2, Are Virulence Factors for Candida Vaginitis","volume":"179","author":"Arancia","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1128\/iai.56.3.626-631.1988","article-title":"Expression of Extracellular Acid Proteinase by Proteolytic Candida spp. during Experimental Infection of Oral Mucosa","volume":"56","author":"Borg","year":"1988","journal-title":"Infect. Immun."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1099\/00222615-13-3-423","article-title":"Inducible proteinase of Candida albicans in diagnostic serology and in the pathogenesis of systemic candidosis","volume":"13","author":"Macdonald","year":"1980","journal-title":"J. Med. Microbiol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1099\/00221287-143-2-349","article-title":"Analysis of secreted aspartic proteinases from Candida albicans: Purification and characterization of individual Sapl, Sap2 and Sap3 isoenzymes","volume":"143","author":"Smolenski","year":"1996","journal-title":"Microbiology"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1128\/jb.175.19.6126-6133.1993","article-title":"Three distinct secreted aspartyl proteinases in Candida albicans","volume":"175","author":"White","year":"1993","journal-title":"J. Bacteriol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1128\/jb.177.18.5215-5221.1995","article-title":"Candida albicans secreted aspartyl proteinases: Isoenzyme pattern is determined by cell type, and levels are determined by environmental factors","volume":"177","author":"White","year":"1995","journal-title":"J. Bacteriol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1515\/CCLM.2001.087","article-title":"Increased Serum and Salivary Immunoglobulins against Candida albicans in HIV-Infected Patients with Oral Candidiasis","volume":"39","author":"Drobacheff","year":"2001","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00126334-200102010-00005","article-title":"Longitudinal study of anti-Candida albicans mucosal immunity against aspartic proteinases in HIV-infected patients","volume":"26","author":"Millon","year":"2001","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1574-695X.1997.tb01080.x","article-title":"Epitope Mapping Candida Albicans Proteinase (SAP 2)","volume":"19","author":"Ghadjari","year":"1997","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1128\/IAI.70.5.2725-2729.2002","article-title":"Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis","volume":"70","author":"Boccanera","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1016\/S0264-410X(02)00218-9","article-title":"Nasal vaccination induces the ability to eliminate Candida colonization without influencing the pre-existing antigen-specific IgE Abs: A possibility for the control of Candida-related atopic dermatitis","volume":"20","author":"Suenobu","year":"2002","journal-title":"Vaccine"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2567.2004.01819.x","article-title":"Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2","volume":"111","author":"Vilanova","year":"2004","journal-title":"Immunology"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.micinf.2007.01.012","article-title":"Murine model of concurrent oral and vaginal Candida albicans colonization to study epithelial host-pathogen interactions","volume":"9","author":"Rahman","year":"2007","journal-title":"Microbes Infect."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1128\/AAC.01072-07","article-title":"Tetracycline-inducible expression of individual secreted aspartic proteases in Candida albicans allows isoenzyme-specific inhibitor screening","volume":"52","author":"Staib","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1574-695X.2011.00802.x","article-title":"A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine","volume":"62","author":"Sandini","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1016\/j.vaccine.2012.04.069","article-title":"A virosomal vaccine against candidal vaginitis: Immunogenicity, efficacy and safety profile in animal models","volume":"30","author":"Amacker","year":"2012","journal-title":"Vaccine"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3390\/pathogens4040697","article-title":"Studies of immune responses in Candida vaginitis","volume":"4","author":"Arancia","year":"2015","journal-title":"Pathogens"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4161\/hv.27714","article-title":"Hybrid phage displaying SLAQVKYTSASSI induces protection against Candida albicans challenge in BALB\/c mice","volume":"10","author":"Wang","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_239","first-page":"1030","article-title":"Immunoprotection by Sap2 and dendritic cells against systemic Candida albicans infection in mice","volume":"34","author":"Xu","year":"2014","journal-title":"J. South. Med. Univ."},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Pericolini, E., Gabrielli, E., Amacker, M., Kasper, L., Roselletti, E., Luciano, E., Sabbatini, S., Kaeser, M., Moser, C., and Hube, B. (2015). Secretory aspartyl proteinases cause vaginitis and can mediate vaginitis caused by Candida albicans in mice. mBio, 6.","DOI":"10.1128\/mBio.00724-15"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/adhm.201500930","article-title":"Genetically Engineered Virus Nanofibers as an Efficient Vaccine for Preventing Fungal Infection","volume":"5","author":"Huai","year":"2016","journal-title":"Adv. Healthc. Mater."},{"key":"ref_242","first-page":"1","article-title":"Novel nanoscale bacteriophage-based single-domain antibodies for the therapy of systemic infection caused by Candida albicans","volume":"6","author":"Dong","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1128\/jb.178.18.5353-5360.1996","article-title":"The Candida albicans HYR1 gene, which is activated in response to hyphal development, belongs to a gene family encoding yeast cell wall proteins","volume":"178","author":"Bailey","year":"1996","journal-title":"J. Bacteriol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1086\/652407","article-title":"Candida albicans Hyr1p Confers Resistance to Neutrophil Killing and Is a Potential Vaccine Target","volume":"201","author":"Luo","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_245","doi-asserted-by":"crossref","unstructured":"Luo, G., Ibrahim, A.S., French, S.W., Edwards, J.E., and Fu, Y. (2011). Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025909"},{"key":"ref_246","doi-asserted-by":"crossref","unstructured":"Uppuluri, P., Lin, L., Alqarihi, A., Luo, G., Youssef, E.G., Alkhazraji, S., Yount, N.Y., Ibrahim, B.A., Bolaris, M.A., and Edwards, J.E. (2018). The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007056"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fimmu.2020.00076","article-title":"Monoclonal IgM Antibodies Targeting Candida albicans Hyr1 Provide Cross-Kingdom Protection Against Gram-Negative Bacteria","volume":"11","author":"Youssef","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1128\/IAI.68.4.1997-2002.2000","article-title":"Reduced virulence of HWP1-deficient mutants of Candida albicans and their interactions with host cells","volume":"68","author":"Tsuchimori","year":"2000","journal-title":"Infect. Immun."},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Nobile, C.J., Andes, D.R., Nett, J.E., Smith, F.J., Yue, F., Phan, Q.T., Edwards, J.E., Filler, S.G., and Mitchell, A.P. (2006). Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog., 2.","DOI":"10.1371\/journal.ppat.0020063"},{"key":"ref_250","doi-asserted-by":"crossref","unstructured":"Dwivedi, P., Thompson, A., Xie, Z., Kashleva, H., Ganguly, S., Mitchell, A.P., and Dongari-Bagtzoglou, A. (2011). Role of Bcr1-activated genes Hwp1 and Hyr1 in Candida albicans oral mucosal biofilms and neutrophil evasion. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016218"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1099\/jmm.0.46737-0","article-title":"Candida albicans HWP1 gene expression and host antibody responses in colonization and disease","volume":"55","author":"Naglik","year":"2006","journal-title":"J. Med. Microbiol."},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"Corouge, M., Loridant, S., Fradin, C., Salleron, J., Damiens, S., Moragues, M.D., Souplet, V., Jouault, T., Robert, R., and Dubucquoi, S. (2015). Humoral immunity links Candida albicans infection and celiac disease. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0121776"},{"key":"ref_253","doi-asserted-by":"crossref","unstructured":"Rosario-colon, J., Eberle, K., Adams, A., Courville, E., and Xin, H. (2021). Candida cell-surface-specific monoclonal antibodies protect mice against candida auris invasive infection. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22116162"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2014.00066","article-title":"Extracellular enolase of Candida albicans is involved in colonization of mammalian intestinal epithelium","volume":"4","author":"Silva","year":"2014","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_255","doi-asserted-by":"crossref","unstructured":"Satala, D., Karkowska-Kuleta, J., Zelazna, A., Rapala-Kozik, M., and Kozik, A. (2020). Moonlighting proteins at the candidal cell surface. Microorganisms, 8.","DOI":"10.3390\/microorganisms8071046"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/infdis\/170.2.390","article-title":"Humoral and cellular immune responses to enolase after alimentary tract colonization or intravenous immunization with candida albicans","volume":"170","author":"Sundstrom","year":"1994","journal-title":"J. Infect. Dis."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1469-0691.1996.tb00198.x","article-title":"Anti-enolase antibodies partially protective against systemic candidiasis in mice","volume":"2","author":"Goessens","year":"1996","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/13693780310001644653","article-title":"Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis","volume":"42","author":"Montagnoli","year":"2004","journal-title":"Med. Mycol."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1016\/j.vaccine.2011.05.030","article-title":"Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice","volume":"29","author":"Li","year":"2011","journal-title":"Vaccine"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1128\/CVI.00396-06","article-title":"Evaluation of a novel enzyme-linked immunosorbent assay to detect immunoglobulin G antibody to enolase for serodiagnosis of invasive candidiasis","volume":"14","author":"Moragues","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_261","doi-asserted-by":"crossref","unstructured":"Li, F.Q., Ma, C.F., Shi, L.N., Lu, J.F., Wang, Y., Huang, M., and Kong, Q. (2013). Diagnostic value of immunoglobulin G antibodies against Candida enolase and fructose-bisphosphate aldolase for candidemia. BMC Infect. Dis., 13.","DOI":"10.1186\/1471-2334-13-253"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/2049-632X.12068","article-title":"An oral vaccine against candidiasis generated by a yeast molecular display system","volume":"69","author":"Shibasaki","year":"2013","journal-title":"Pathog. Dis."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2015.00920","article-title":"Serological response and diagnostic value of recombinant candida cell wall protein enolase, phosphoglycerate kinase, and \u03b2-glucosidase","volume":"6","author":"He","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_264","doi-asserted-by":"crossref","unstructured":"Leu, S.J., Lee, Y.C., Lee, C.H., Liao, P.Y., Chiang, C.W., Yang, C.M., Su, C.H., Ou, T.Y., Liu, K.J., and Lo, H.J. (2020). Generation and Characterization of Single Chain Variable Fragment against Alpha-Enolase of Candida albicans. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21082903"},{"key":"ref_265","doi-asserted-by":"crossref","unstructured":"Djordjevic, J.T. (2010). Role of phospholipases in fungal fitness, pathogenicity, and drug development-lessons from Cryptococcus neoformans. Front. Microbiol., 1.","DOI":"10.3389\/fmicb.2010.00125"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ijmm.2006.03.003","article-title":"Inactivation of the phospholipase B gene PLB5 in wild-type Candida albicans reduces cell-associated phospholipase A2 activity and attenuates virulence","volume":"296","author":"Theiss","year":"2006","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1128\/CMR.13.1.122","article-title":"Potential role of phospholipases in virulence and fungal pathogenesis","volume":"13","author":"Ghannoum","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"26078","DOI":"10.1074\/jbc.273.40.26078","article-title":"Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans","volume":"273","author":"Leidich","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1099\/00221287-147-9-2585","article-title":"Reintroduction of the PLB1 gene into Candida albicans restores virulence in vivo","volume":"147","author":"Mukherjee","year":"2001","journal-title":"Microbiology"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1099\/mic.0.049395-0","article-title":"Hyphal induction in the human fungal pathogen Candida albicans reveals a characteristic wall protein profile","volume":"157","author":"Heilmann","year":"2011","journal-title":"Microbiology"},{"key":"ref_271","first-page":"1","article-title":"Epitope-Based Peptide Vaccine Design against Fructose Bisphosphate Aldolase of Candida glabrata: An Immunoinformatics Approach","volume":"2021","author":"Hassan","year":"2021","journal-title":"J. Immunol. Res."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.vaccine.2015.11.035","article-title":"Active Immunizations with Peptide-DC Vaccines and Passive Transfer with Antibodies Protect Neutropenic Mice against Disseminated Candidiasis","volume":"34","author":"Xin","year":"2016","journal-title":"Vaccine"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1016\/j.vaccine.2018.08.011","article-title":"Phage vaccines displaying YGKDVKDLFDYAQE epitope induce protection against systemic candidiasis in mouse model","volume":"36","author":"Shi","year":"2018","journal-title":"Vaccine"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.micpath.2018.08.024","article-title":"Moonlighting proteins induce protection in a mouse model against Candida species","volume":"124","author":"Moreno","year":"2018","journal-title":"Microb. Pathog."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.vaccine.2019.03.061","article-title":"Design of a mimotope-peptide based double epitope vaccine against disseminated candidiasis","volume":"37","author":"Xin","year":"2019","journal-title":"Vaccine"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1016\/j.vaccine.2021.06.001","article-title":"Synthetic conjugate peptide Fba-Met6 (MP12) induces complement-mediated resistance against disseminated Candida albicans","volume":"39","author":"Adams","year":"2021","journal-title":"Vaccine"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1128\/iai.61.10.4263-4271.1993","article-title":"Glycolytic enzymes of Candida albicans are nonubiquitous immunogens during candidiasis","volume":"61","author":"Swoboda","year":"1993","journal-title":"Infect. Immun."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1002\/pmic.200400929","article-title":"Low virulent strains of Candida albicans: Unravelling the antigens for a future vaccine","volume":"4","author":"Molero","year":"2004","journal-title":"Proteomics"},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1615-9861(200104)1:4<550::AID-PROT550>3.0.CO;2-W","article-title":"Analysis of the serologic response to systemic Candida albicans infection in a murine model","volume":"1","author":"Pitarch","year":"2001","journal-title":"Proteomics"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1074\/jbc.RA119.011084","article-title":"Copper-only superoxide dismutase enzymes and iron starvation stress in Candida fungal pathogens","volume":"295","author":"Schatzman","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1091\/mbc.e03-03-0179","article-title":"Superoxide dismutases in Candida albicans: Transcriptional regulation and functional characterization of the hyphal-induced SOD5 gene","volume":"15","author":"Martchenko","year":"2004","journal-title":"Mol. Biol. Cell."},{"key":"ref_282","doi-asserted-by":"crossref","unstructured":"K\u00f6nig, A., Hube, B., and Kasper, L. (2020). The Dual Function of the Fungal Toxin Candidalysin during Candida albicans-Macrophage Interaction and Virulence. Toxins, 12.","DOI":"10.3390\/toxins12080469"},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1021\/pr5007944","article-title":"Proteomics unravels extracellular vesicles as carriers of classical cytoplasmic proteins in Candida albicans","volume":"14","author":"Parra","year":"2015","journal-title":"J. Proteome Res."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2958.2008.06528.x","article-title":"Candida albicans cell surface superoxide dismutases degrade host-derived reactive oxygen species to escape innate immune surveillance","volume":"71","author":"Frohner","year":"2009","journal-title":"Mol. Microbiol."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1074\/jbc.RA118.007095","article-title":"Exploiting the vulnerable active site of a copper-only superoxide dismutase to disrupt fungal pathogenesis","volume":"294","author":"Robinett","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/2049-632X.12003","article-title":"Time-course proteomic profile of Candida albicans during adaptation to a fetal serum","volume":"67","author":"Aoki","year":"2013","journal-title":"Pathog. Dis."},{"key":"ref_287","doi-asserted-by":"crossref","unstructured":"Shibasaki, S., Karasaki, M., Aoki, W., and Ueda, M. (2018). Molecular and physiological study of Candida albicans by quantitative proteome analysis. Proteomes, 6.","DOI":"10.3390\/proteomes6030034"},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4265\/bio.19.51","article-title":"Evaluation of Mdh1 protein as an antigenic candidate for a vaccine against candidiasis","volume":"19","author":"Shibasaki","year":"2014","journal-title":"Biocontrol Sci."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"5786","DOI":"10.1016\/j.vaccine.2017.08.082","article-title":"ying The vaccines and antibodies associated with Als3p for treatment of Candida albicans infections","volume":"35","author":"Sui","year":"2017","journal-title":"Vaccine"},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1080\/22221751.2020.1840927","article-title":"Preventing Candida albicans from subverting host plasminogen for invasive infection treatment","volume":"9","author":"Chen","year":"2020","journal-title":"Emerg. Microbes Infect."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/10\/1159\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:11:21Z","timestamp":1760166681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/10\/1159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,10]]},"references-count":290,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["vaccines9101159"],"URL":"https:\/\/doi.org\/10.3390\/vaccines9101159","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,10]]}}}